Crohn’s and Colitis happen when the body’s immune system starts to attack itself rather than protect the body, and it is thought to be caused by a mix of genes, bacteria in the gut, and possibly ...

OpenBiome, which provides fecal microbiota transplantation material for US patients with severe/fulminant C difficile ...

When it comes to blood tests, doctors suggest you speak about these six with your primary healthcare provider.

UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...

VELSIPITY (R) was officially approved by the Pharmaceutical Administration Bureau of Macau in April 2024, and was introduced in the Greater Bay Area in October through the "Hong Kong and Macau ...

Inflammatory bowel disease (IBD), consisting primarily of ulcerative colitis and Crohn's disease, is a group of debilitating ...

Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is ...

Immune-Mediated Colitis UNLOXCYT can cause immune-mediated colitis, which may present with diarrhea, abdominal pain, and lower gastrointestinal bleeding. Cytomegalovirus infection/reactivation has ...

Researchers confirmed the long-term safety profile of ozanimod for the treatment of moderate to severe UC or RMS.

These 1,395 physicians, nominated by their peers, are the right prescription for what ails you.

Crohn’s disease (CD) is a chronic idiopathic inflammatory bowel disease, with a complex aetiology involving genetic, ...